2/23/18. Age of Anxiety: Transforming Qualms into Calm. Disclosures. Objectives. I have nothing to disclose
|
|
- Neal Lucas
- 5 years ago
- Views:
Transcription
1 Age of Anxiety: Transforming Qualms into Calm Rosa Kim, MD Assistant Professor and Attending Child Psychiatrist Medical College of Wisconsin and Children s Hospital of Wisconsin Disclosures I have nothing to disclose Objectives Upon completion of this course, you will be able to 1) diagnose the second most common mental illness in children 2) identify the primary therapeutic interventions to treat anxiety 3) dose, titrate, and monitor medications as treatments of anxiety 1
2 Most Common Mental Illnesses in Children 1. ADHD prevalence: 13% presents ages Anxiety Disorders prevalence: 8-10% presents ages Depression prevalence: 2-8% presents ages Anxiety Disorders vs. Normal Anxiety Normal Anxiety Predictable triggers (e.g., exams) Proportionate reaction Can happen any time throughout development Pathological Anxiety Triggers are normative experiences Excessive reaction Predictable ages of onset for subtypes Genetics and Environment Genetic vulnerability exists. Anxiety is self-perpetuating. Anxiety is contagious. 2
3 Anxiety Disorders Separation Anxiety Disorder Selective Mutism Specific Phobia Social Anxiety Disorder Panic Disorder Agoraphobia Generalized Anxiety Disorder Unspecified Anxiety Disorder Other Anxiety Disorders Obsessive-Compulsive and Related Disorders: o OCD o Body Dysmorphic Disorder o Hoarding Disorder o Trichotillomania o Excoriation Disorder Other Anxiety Disorders (cont d) Trauma- and Stressor-Related Disorders o Reactive Attachment Disorder o Disinhibited Social Engagement Disorder o PTSD o Acute Stress Disorder o Adjustment Disorders 3
4 Other Disorders with Anxiety Symptoms Neurodevelopmental Disorders (intellectual disability, ASD, ADHD, specific learning disorders, etc.) Mood Disorders Psychotic Disorders Somatic Symptoms Disorders Feeding and Eating Disorders Gender Dysphoria Substance Use Disorders Personality Disorders Anxiety Disorders Separation Anxiety Disorder Selective Mutism Specific Phobia Social Anxiety Disorder Panic Disorder Agoraphobia Generalized Anxiety Disorder Unspecified Anxiety Disorder Anxiety Patients rarely answer yes to the question, Is anxiety a problem for you? homesick (separation anxiety) worry worts (GAD) self-conscious, shy (SAD) worries often easily stressed 4
5 Characteristics Common to Anxiety Disorders Characteristics Common to Anxiety Disorders hypervigilance poor adjustment to novel situations biased interpretation of experiences as threatening avoidance as a coping strategy catastrophic reactions parental accommodations midline physical symptoms Midline Physical Symptoms tension headache dizziness hyperventilation lump in throat chest pain abdominal pain bowel and bladder urgency 5
6 Other Symptoms Other Symptoms sleep problems eating problems persistent need for reassurance inattention and poor school performance explosive outbursts avoidance of activities not necessarily pervasive Separation Anxiety Disorder excessive concern regarding separation from home or attachment figures the earliest of non-ocd anxiety disorders to present (around ages 6-8 years) see this in August and September 6
7 Selective Mutism variant of social anxiety disorder (more severe, earlier onset) has an ability to speak occurs more often in younger children Specific Phobia 70% have another anxiety disorder Social Anxiety Disorder fear of social or performance situations o generalized o specific presents in early childhood, but not impairing until adolescence 7
8 Panic Disorder presents later in adolescence attacks of anxiety persistent worry about the next panic attack avoidance behavior related to the attacks Generalized Anxiety Disorder excessive worry or fearfulness unable to control the worry impairment or distress presents around ages 9-11 years present in October, November (1 st report card) OCD Prominent Obsessions or Compulsions o dirt, germs, or other contamination o ordering and arranging o checking o repetitive acts Impairing or time consuming 8
9 PTSD true stressful event re-experiencing of the event avoidance and numbing increased arousal negative thoughts, feelings, and moods Anxiety and Substance Use Disorder Adolescents with anxiety/ptsd have a 2-fold risk for substance use disorder have anxiety as a trigger for substance use Diagnosing Anxiety SCARED (Screen for Child Anxiety and Related Emotional Disorders; child version and parent version) SCAS (Spence Children s Anxiety Scale) MASC (Multidimensional Anxiety Scale for Children) 9
10 First-Line Treatment of Anxiety Cognitive-Behavioral Therapy (CBT) should be the first-line treatment for both mild to moderate anxiety. Components of CBT Psychoeducation Techniques for managing somatic reactions (relaxation training, diaphragmatic breathing) Cognitive restructuring by identifying and challenging anxiety-provoking thoughts Practicing problem-solving Systematic exposures Relapse prevention Psychopharmacological Treatment of Anxiety 10
11 Psychopharmacological Treatment of Anxiety For severe cases, the recommendation is for CBT plus medications. SSRIs are the pharmacological treatment of choice. Anxiety typically requires higher doses of SSRIs and longer duration of treatment. Anxiety Treatment Algorithm 1) Optimize first-choice SSRI. 2) If that doesn t work, try another SSRI. 3) If that doesn t work, try another class. SSRIs Recommended monitoring: o monitor weekly for the first month (phone contact is sufficient) o biweekly for the next month o monthly thereafter 11
12 SSRI Contraindications Serotonin Syndrome and MAOIs o Do not use SSRIs within14 days to 5 weeks after stopping an MAOI. Potential Adverse Effects of SSRIs activation bipolar switch stomach upset platelet dysfunction appetite change serotonin syndrome frontal lobe symptoms QTc prolongation SSRI Warning FDA black box warning: 12
13 Suicidal Ideation MDD: NNT = 10 OCD: NNT = 5 Non-OCD anxiety disorders: NNT = 3 MDD: NNH = 100 OCD: NNH = 200 Non-OCD anxiety disorders: NNH = ~140 SSRI Metabolism SSRIs are metabolized, in part, by the cytochrome P450 system and should be administered with caution when used with other medications metabolized via this pathway. SSRI Titration Psychoeducation! Don t titrate too slowly. 13
14 Dosing Use clinical trials as guidelines: Fluoxetine: 40mg by week 12 (TADS, 2004) Sertraline: mg by week 10 (RUPP, 2001) Citalopram: 40mg (Uchida, 2017) Escitalopram: 20mg (Emslie, 2009) Duloxetine: mg (Strawn, 2015) Treatment Duration Continue medications for at least 6-12 months following symptom remission. CBT is a durable treatment. Anxiety tends to be more constitutional. SSRI Discontinuation Doses should be tapered slowly while the patient is monitored for potential symptom recurrence. The exception to this is fluoxetine (Prozac). 14
15 SSRIs Name Fluoxetine (Prozac) Sertraline (Zoloft) Citalopram (Celexa) Escitalopram (Lexapro) Paroxetine (Paxil) Fluvoxamine (Luvox) Dose Range 10-60mg mg 10-40mg 5-20mg 10-60mg mg in divided doses Starting Dose Titration 10-20mg by 10-20mg mg by 25-50mg 10mg by 10-20mg 5-10mg by 5-10mg 10mg by 10mg 25mg by 25mg; divide dose at 100mg FDA Approval >8yo for MDD >7yo for OCD >6yo for OCD >12yo for MDD >8yo for OCD Notes long half-life; most likely to cause activation more likely to cause GI symptoms when initiated risk of QTc prolongation at dose > 40mg sedating; may cause QTc prolongation in overdose Avoid! used mainly for treatmentrefractory OCD SNRIs Duloxetine (Cymbalta) o the only medication FDA-approved for non- OCD anxiety disorders in the pediatric population (Strawn, 2015) o >7yo o less likely to cause activation o common side effect: stomach aches OCD Considerations Tic-related OCD (repetitive behaviors, etc.) typically requires SSRI + atypical antipsychotic. Hoarding is its own diagnosis and also doesn t respond as well to SSRIs. OCD requires at least ~6 months of treatment to achieve efficacy. 15
16 Additional Medications for Anxiety Beta-blockers may be used as second-line agents for specific phobias and performance anxiety. Benzodiazepines can be used during the initiation phase of SSRIs. They should then be tapered off. Hydroxyzine may be useful. Buspirone can be used for children with ASD and/or as an augmenter. Sleep Sleep Sleep hygiene: wake up at the same time every day limit caffeine after 2 PM limit screen time (timetimer.com, f.lux, etc.) Shut-I app (CBT for insomnia) Medications: melatonin clonidine/kapvay trazodone 16
17 Other Treatments Other Treatments Meditation apps: Headspace, Insight Timer Gratitude Breathing exercises: breaths (Google breath handout ) Recommendations to Parents 17
18 Recommendations to Parents Limit electronics. Normalize the range of emotions. Avoid excessive praise. Teach children emotional skills. Be a guide, not a protector. Address your own guilt and fear. Provide children with play time. Be the parent! Parent Resources Books: Keys to Parenting Your Anxious Child by Katharina Manassis, MD Helping Your Anxious Child: A Step-by-Step Guide for Parents by Ronald Rapee, PhD You and Your Anxious Child by Anne Marie Albano, PhD Additional References American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5 th Edition. Arlington, VA, American Psychiatric Association, Birmaher, Boris; Brent, David. Practice Parameters for the Assessment and Treatment of Children and Adolescents with Depressive Disorders. JAACAP, 46:11, , Connolly, Sucheta D.; Bernstein, Gail A. Practice Parameters for the Assessment and Treatment of Children and Adolescents with Anxiety Disorders. JAACAP, 46:2, , Dietle, A. QTc prolongation with antidepressants and antipsychotics. U.S. Pharmacist. 2015: HS Moran, Amy. 10 Reasons Why Today s Teenagers Are So Anxious. Psychology Today, November Riddle, Mark. Pediatric Psychopharmacology for Primary Care. American Academy of Pediatrics, Stahl, Stephen M. Essential Psychopharmacology: The Prescriber s Guide. Press Syndicate of the University of Cambridge, Visser et al. National Survey of Children s Health, Wehry, Ann et al. Assessment and Treatment of Anxiety Disorders in Children and Adolescents. Curr Psychiatry Rep, 2015 July; 17(7);
19 Contact Information Rosa Kim, MD Assistant Professor Division of Child & Adolescent Psychiatry Department of Psychiatry and Behavioral Medicine Medical College of Wisconsin (414) Physician Referral and Consultation: (800)
Children s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationManagement Of Depression And Anxiety
Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationHelping Your Children Learn to Handle Their Own Anxiety Winter 2015
Helping Your Children Learn to Handle Their Own Anxiety Winter 2015 Daniel G. Shapiro, M.D. Developmental and Behavioral Pediatrics drdanshapiro@gmail.com www.raisingyourchallengingchild.com Aristotle
More informationTreatment of Pediatric Anxiety Disorders in the Primary Care Setting. June 23, 2018 Aditi Sharma, MD
Treatment of Pediatric Anxiety Disorders in the Primary Care Setting June 23, 2018 Aditi Sharma, MD Imagine your anxious trigger Anxiety is Normal (to a degree) Protective Powerful Trigger Anxious reactivity
More informationfor anxious and avoidant behaviors.
Summary of the Literature on the Treatment of Anxiety Disorders in Children and Adolescents Sucheta D. Connolly, M.D.* Non-OCD anxiety disorders in youth are common and disabling, with 12-month prevalence
More informationTreatment of Anxiety (without benzos)
Treatment of Anxiety (without benzos) Alison C. Lynch MD MS Clinical Professor Departments of Psychiatry and Family Medicine University of Iowa Health Care None Disclosures Overview/objectives Review common
More informationDisclosure Information
Disclosure Information I have no financial relationships to disclose. I will discuss the off label use of several depression and anxiety medications in pediatric population Pediatric Depression & Anxiety
More informationDisclosures. Questions. A Developmental Approach. Goals and objectives 4/3/2018 FEARS AND TEARS: TREATING ANXIETY AND DEPRESSION IN PRIMARY CARE
Disclosures FEARS AND TEARS: TREATING ANXIETY AND DEPRESSION IN PRIMARY CARE I have no financial interests I WILL be talking about non FDA approved uses of medications for anxiety and depression in children
More informationDisclosures. Learning Objectives. Psychopharmacology of Pediatric Anxiety and Depression 5/4/2017
Psychopharmacology of Pediatric Anxiety and Depression Susan Sharp, DO Clinical Assistant Professor of Child and Adolescent Psychiatry Kansas University Medical Center The Children's Mercy Hospital, 2017
More informationHow to Manage Anxiety
How to Manage Anxiety Dr Tony Fernando Psychological Medicine University of Auckland Auckland District Health Board www.insomniaspecialist.co.nz www.calm.auckland.ac.nz Topics How to diagnose How to manage
More informationOverview. Part II: Part I: Screening for Depression and Anxiety Risk Assessment Diagnosis of Depressive Disorders
1 Learning Objectives 1. Providers will become familiar with methods of screening for depression and anxiety. 2. Providers will become more comfortable with diagnosis and management of these common pediatric
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationAn Overview of Anxiety and Mood Disorders in Youth
An Overview of Anxiety and Mood Disorders in Youth Mary Kay Nixon MD FRCPC Clinical Associate Professor, UBC Affliliate Associate Professor, UVic Family Physicians Conference February 22, 2012 Victoria,
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationCHILDHOOD/ADOLESCENT ANXIETY DISORDERS: EVALUATION AND TREATMENT
CHILDHOOD/ADOLESCENT ANXIETY DISORDERS: EVALUATION AND TREATMENT PHILIP L. BAESE, MD ASSISTANT PROFESSOR OF PSYCHIATRY CHIEF, DIVISION OF CHILD AND ADOLESCENT PSYCHIATRY UNIVERSITY OF UTAH, SCHOOL OF MEDICINE
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationManaging Anxiety Disorder in Primary Care
Saturday General Session Managing Anxiety Disorder in Primary Care Chris Ticknor, MD Private Practice, Psychiatry Adjunct Professor of Psychiatry UT Health Science Center at San Antonio San Antonio, Texas
More informationQuick Guide to Common Antidepressants-Adults
Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationJoe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health
Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health Solutions, PLLC www.bartoncbt.com Academic and Pop-Culture
More informationLisa Goldstein, MD Child and Adolescent and Adult Psychiatrist
Lisa Goldstein, MD Child and Adolescent and Adult Psychiatrist Past President, Pennsylvania Branch of the International Dyslexia Association drlisa@lisagoldsteinmd.com April 2018 No disclosures, No conflicts.
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationShort Clinical Guidelines: General Anxiety Disorder (GAD)
Definition is one of the most prevalent psychiatric disorders seen in the primary care office and is characterized by excessive anxiety and worry about a number of events that cause clinically significant
More informationContemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd) 10/2/2014
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Neurotransmitters are associated with anxiety. low
More informationBe a Warrior, Not a Worrier: Anxiety Disorders in the Pediatric Setting
Be a Warrior, Not a Worrier: Anxiety Disorders in the Pediatric Setting Ramon Solhkhah, M.D. Professor and Founding Chair, Department of Psychiatry & Behavioral Health Hackensack Meridian School of Medicine
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationPediatric Depression and Anxiety. Cecilia Margret, MD PhD MPH PAL Conference
Pediatric Depression and Anxiety Cecilia Margret, MD PhD MPH PAL Conference I have no relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial
More information2/9/2016. Anxiety. Early Intervention for childhood Mental Health issues. ANXIETY DISORDERS in Children and Adolescents.
ANXIETY DISORDERS in Children and Adolescents. Joy Lauerer DNP PMHCNS BC Discussion Points Anxiety Early Intervention for childhood Mental Health issues Why? Important to long term health outcomes! What
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationAnxiety in Youth: Identification, Management, & Referral
Anxiety in Youth: Identification, Management, & Referral Martin E. Franklin, Ph.D. Associate Professor of Psychiatry University of Pennsylvania School of Medicine Prelude to the Talk: Anxiety & Its Disorders
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationPEDIATRIC DEPRESSION AND ANXIETY
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences PEDIATRIC DEPRESSION AND ANXIETY CECILIA MARGRET MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES The University
More informationPsychiatric Treatment of the Concussed Athlete
Psychiatric Treatment of the Concussed Athlete Eastern Athletic Trainers Association January 11 th, 2015 Alexander S. Strauss, MD Centra, P.C. E-MAIL: DRSTRAUSS@ALEXSTRAUSSMD.COM Evidence Mounts Linking
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationWhen The Kids Aren t Alright
When The Kids Aren t Alright Evaluation and treatment strategies for childhood anxiety and depression in primary care Megan Chiarelli, MD Child & Adolescent Psychiatry, General Psychiatry Medical Director
More informationAN OVERVIEW OF ANXIETY
AN OVERVIEW OF ANXIETY Fear and anxiety are a normal part of life. Normal anxiety keeps us alert. Intervention is required when fear and anxiety becomes overwhelming intruding on a persons quality of life.
More informationFor: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013
For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationPsychopharmacology for Non-MDs - Dr. Suzanne Dieter. March 10, 2017 PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS LEARNING OBJECTIVES
LEARNING OBJECTIVES PEDIATRIC PSYCHOPHARMACOLOGY FOR NON-MDS, MD New York, NY Member, American Academy of Child and Adolescent Psychiatry Understand the role a child psychiatrist can play as part of a
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationModerate depression, low/moderate safety risk, age < 12
Depressive Disorders Patterns of excessive depressed or irritable moods, with associated neurovegetative symptoms (sleep, appetite, concentration), guilty feelings, suicidality, guilt, and functional impairment
More informationLet s Talk About Treatment
What Doesn t Work Let s Talk About Treatment Lisa R. Terry, LPC What we ve tried Talk therapy- You can t talk you way out of a medical disorder Play Therapy Family Therapy Psychoanalysis While these are
More informationAnxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when
Anxiety s J. H. Atkinson, M.D. HIV Neurobehavioral Research Center University of California, San Diego Department of Psychiatry & Veterans Affairs Healthcare System, San Diego Materials courtesy of Dr.
More informationCBT FOR ANXIETY (CBT-A): WHAT CAN I DO WITH MY PATIENT INSTEAD OF GIVING THEM A PRN BENZODIAZEPINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences CBT FOR ANXIETY (CBT-A): WHAT CAN I DO WITH MY PATIENT INSTEAD OF GIVING THEM A PRN BENZODIAZEPINE PATRICK J. RAUE,
More informationDSM Comparison Chart DSM-5 (Revisions in bold)
317.0-318.2 DSM Comparison Chart DSM-IV-TR DSM-5 (Revisions in bold) Multi-axial system s Usually First Diagnosed in Infancy, Childhood and Adolescence Single line diagnosis with specifiers Neurodevelopmental
More informationWomen, Mental Health, and HIV
Women, Mental Health, and HIV Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What is Mental Health? Refers to emotional, psychological, social
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Theories: Anxiety Disorders. Theories: Anxiety Disorders (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 18 Anxiety Disorders Theories: Anxiety Disorders Biological changes in the brain Noradrenergic system is sensitive to norepinephrine;
More informationHDSA welcomes you to Caregiver s Corner. Funded by an educational grant from
HDSA welcomes you to Caregiver s Corner Funded by an educational grant from Caregiver s Corner Webinar, DATE Managing Psychiatric Symptoms Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics
More informationFamily Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University
APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure
More informationANXIETY DISORDERS IN THE ELDERLY IMPACT OF LATE-LIFE ANXIETY CHANGES IN DSM-5 THE COSTS 6/4/2015 LATE-LIFE ANXIETY TOPICS TO BE COVERED
LATE-LIFE ANXIETY TOPICS TO BE COVERED ANXIETY DISORDERS IN THE ELDERLY Dr. Lisa Talbert Classes of Anxiety Disorders Diagnosis Comorbidities Pharmacologic Management Psychological Management LATE LIFE
More informationPediatrics Grand Rounds 5 March University of Texas Health Science Center at San Antonio I-1
Diagnosis and Treatment of Depression in Children and Adolescents Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department of Psychiatry The Disclosures
More informationAnxiety PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 37
Anxiety PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 37 Anxiety Problem? Unexplained somatic complaints? Safety check: Neglect/Abuse? Drug abuse? Medical cause? (i.e. medication effects, asthma Think
More informationFive Changes in DSM 5 Principles for Primary Care. Tom Janzen, M.D. STEGH Mental Health May 14, 2014
Five Changes in DSM 5 Principles for Primary Care Tom Janzen, M.D. STEGH Mental Health May 14, 2014 Overall Learning Objectives Review 5 changes to DSM 5 which have significance for Family Physicians Examine
More informationUnderstanding anxiety disorders in children
What questions will be covered? Anxiety in Children: What GPs need to know PROFESSOR JENNIE HUDSON, Department of Psychology Understanding anxiety disorders in children Are Anxiety Disorders something
More informationPharmacological Treatment of Anxiety & Depressive Disorders
Pharmacological Treatment of Anxiety & Depressive Disorders Dr Gary Jackson (MB BCh FRCPsych) Consultant Psychiatrist The Priory Hospital Chelmsford Wellesley Hospital Southend-on-Sea Medical Secretary:
More informationResident Rotation: Collaborative Care Consultation Psychiatry
Resident Rotation: Collaborative Care Consultation Psychiatry Anna Ratzliff, MD, PhD Ramanpreet Toor, MD James Basinski, MD With contributions from: Jürgen Unützer, MD, MPH, MA Jennifer Sexton, MD, Catherine
More informationIncreasing Your Confidence in Treating Pediatric Depression and Anxiety
Increasing Your Confidence in Treating Pediatric Depression and Anxiety Erin Dillon-Naftolin, MD November 19, 2016 PAL Conference I have no relevant financial relationships with the manufacturer(s) of
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationKari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD
IN PRIMARY CARE June 17, 2010 Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington Defining and assessing Approach for doing differential diagnosis of Best
More informationObsessive/Compulsive Disorder
Obsessive/Compulsive Disorder An Overview of the Diagnosis, Symptoms, Assessment and Treatment in Behavioral Health Martin J. Harrington M.D., Staff Child/Adolescent Psychiatrist Children s Hospital and
More informationTools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry
Tools that make a difference in mental health symptoms of autistic spectrum children Sumru Bilge-Johnson M.D. Program Director of Child Psychiatry Fellowship Associate Professor, Child Psychiatry NEOMED
More informationThe New DSM- 5: A Clinical Discussion Through A Developmental Lens. Marit E. Appeldoorn, MSW, LICSW
The New DSM- 5: A Clinical Discussion Through A Developmental Lens Marit E. Appeldoorn, MSW, LICSW 612-412- 1159 mappeldoornlicsw@gmail.com Introductions and My (Not- So- Bad) Dilemma What We Already Know
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationAnxiety Disorders.
Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN
UW PACC Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL
More informationContemporary Psychiatric-Mental Health Nursing. Theories: Anxiety Disorders. Theories: Anxiety Disorders - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 18 Anxiety and Dissociative Disorders Theories: Anxiety Disorders Biological changes in the brain Noradrenergic system is sensitive to norepinephrine;
More informationIlluminating the Black Box: Antidepressants, Youth and Suicide
Illuminating the Black Box: Antidepressants, Youth and Suicide David H. Rubin, M.D. Executive Director, MGH Psychiatry Academy Director, Postgraduate Medical Education Director, Child and Adolescent Psychiatry
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationForty-Eighth Annual Teaching Conference Pediatrics for the Practitioner -UT Health Science Center San Antonio School of Medicine June 10-12, 2011
Recognizing OCD and Anxiety Disorders in Children Adelaide Robb, MD Associate Professor Psychiatry and Pediatrics Source Advisory Board Disclosure Speaker s Bureau Bristol Myers Squibb Epocrates Research
More informationANTI-DEPRESSANT MEDICATIONS
ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationDIAGNOSTIC CRITERIA (ICD 10)
DEPRESSION Depression is a major public health problem around the world Affects 1:5 older people living in the community Affects 2:5 older people living in care homes Various treatment options available,
More informationChanges to the Organization and Diagnostic Coverage of the SCID-5-RV
Changes to the Organization and Diagnostic Coverage of the SCID-5-RV Core vs. Enhanced SCID configuration A number of new disorders have been added to the SCID-5-RV. To try to reduce the length and complexity
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More informationANXIETY: SCREENING, DIFFERENTIAL DIAGNOSIS, TREATMENT MONITORING
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences ANXIETY: SCREENING, DIFFERENTIAL DIAGNOSIS, TREATMENT MONITORING DEB COWLEY MD OCTOBER 20, 2016 OBJECTIVES At the
More informationAntidepressants Choosing the Right One
Antidepressants Choosing the Right One Dr Lim Boon Leng Consultant Psychiatrist Dr BL Lim Centre For Psychological Wellness #09-09, Gleneagles Medical Centre, 6 Napier Rd, S258499 www.psywellness.com.sg
More informationAnxiety disorders are remarkably common among pediatric
Web audio at CurrentPsychiatry.com Dr. Strawn: Predictors of outcome and multimodal treatment for pediatric anxiety An evidence-based approach to treating pediatric anxiety disorders Research supports
More informationAnxiety Disorders: First aid and when to refer on
Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationPSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust
PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions
More informationReviews/Evaluations. Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients. Pharmacotherapeutic Options
Reviews/Evaluations Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients Childhood major depressive disorder (MDD) has become recognized as a serious and common illness affecting between
More informationPanic disorder is a chronic and recurrent illness associated
CLINICAL PRACTICE GUIDELINES Management of Anxiety Disorders. Panic Disorder, With or Without Agoraphobia Epidemiology Panic disorder is a chronic and recurrent illness associated with significant functional
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationAverage dose zoloft for ocd and anxiety
Average dose zoloft for ocd and anxiety Gogamz Menu DESCRIPTION. Selective serotonin reuptake inhibitor (SSRI). Approved for depression, OCD, panic disorder, PTSD, premenstrual-dysphoric disorder (PMDD),
More informationPharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests
Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) University of Texas Health Science Center San Antonio Pharmacotherapy Education and Research Center (PERC) 7703 Floyd Curl Drive - MSC 6220 San
More informationRealities of Depression in Primary Care Setting
Realities of Depression in Primary Care Setting Jaroslava Salman, MD Department of Supportive Care Medicine Division of Psychiatry Click to edit Master Presentation Date August 4 th 2018 Disclosure I have
More information